Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Indiana: The Definitive Guide for Patients and Families

Finding out that the medical device implanted to help your body heal is actually causing it harm is a traumatic experience that no woman in Indiana should have to face alone. Whether you underwent a post-mastectomy reconstruction at a major institution like the Indiana University (IU) Health Simon Comprehensive Cancer Center in Indianapolis, or sought a cosmetic lift or augmentation at a high-volume aesthetic practice in Fort Wayne, South Bend, or Evansville, you likely trusted that the materials used in your surgery were as safe as they were effective.

At Attorney911—The Manginello Law Firm, PLLC—we have spent years representing individuals against powerful institutions and manufacturers. Our managing partner, Ralph Manginello, has been licensed by the State Bar of Texas (Bar Card Number 24007597) since 1998, bringing over twenty-seven years of continuous litigation experience to every case. Alongside associate attorney Lupe Peña, who conducts full client consultations in fluent Spanish, we prosecute high-profile, multi-defendant institutional liability cases, such as our current leadership in the Bermudez v. Pi Kappa Phi litigation. We understand the complex regulatory and medical intersection of defective device claims, and we are committed to providing Indiana families with the educational resources they need to navigate this crisis.

The following guide is a comprehensive resource for Indiana residents who have experienced complications from surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffolds used in breast surgery. We believe that knowledge is the first step toward agency. If you have questions about your specific situation in Indiana, you can reach us at 1-888-ATTY-911 (1-888-288-9911) for a confidential, no-obligation consultation.

Understanding the Devices: Mesh, ADM, and Scaffolds in Indiana Breast Surgery

In the world of Indiana breast surgery, three categories of products are frequently used to provide support to breast implants or to reinforce thinning tissue. For many years, these devices were marketed as “internal bras”—scaffolds meant to hold an implant in place, prevent “bottoming out,” and ensure a more natural aesthetic result. However, many patients in Indiana were never told that these devices were being used “off-label,” meaning they were never cleared or approved by the FDA specifically for use in the breast.

1. Acellular Dermal Matrix (ADM)

Acellular Dermal Matrix, or ADM, is a biologic material derived from donated human or animal skin. In a laboratory setting, the cells are removed from the donor tissue, leaving behind a “matrix” of collagen and connective proteins. When implanted into a patient in Indiana, this matrix is intended to act as a scaffold into which the patient’s own cells can grow. Common brands utilized in Indiana hospitals include:

• AlloDerm and AlloDerm RTU (Allergan / AbbVie)
• Strattice (Allergan / AbbVie)
• FlexHD and FlexHD Pliable (MTF Biologics)
• AlloMax (C.R. Bard / Becton Dickinson)
• SurgiMend (Integra LifeSciences)

2. Bioabsorbable Scaffolds

Bioabsorbable scaffolds are synthetic materials designed to be slowly absorbed by the body. The goal is for the scaffold to provide temporary support while the patient’s own tissue strengthens, eventually dissolving completely. The most common material used in Indiana for this purpose is poly-4-hydroxybutyrate (P4HB). Brand names that have faced significant scrutiny in Indiana include:

• GalaFLEX (including GalaFLEX 3D and 3DR)
• Phasix Mesh
• DuraSorb

3. Synthetic Surgical Mesh

While less common for primary reconstruction today, permanent synthetic meshes—often made of polypropylene—were sometimes used in Indiana breast surgeries. These materials were originally designed for hernia repair and lack the flexibility required for the delicate environment of breast tissue, leading to high rates of erosion and chronic pain for women across Indiana.

The FDA Regulatory Failure: Why Indiana Patients Were Not Warned

One of the most frustrating aspects for Indiana patients is the discovery that these devices were often used without specific FDA approval for breast applications. The vast majority of ADM and scaffold products utilized in Indiana entered the market through the 510(k) clearance pathway.

Under 21 USC §360c and 21 CFR Part 807, the 510(k) pathway allows a manufacturer to market a device if they can show it is “substantially equivalent” to a “predicate device” already on the market. This is a comparative process, not an evaluative one. In other words, the FDA does not necessarily test the device for safety and effectiveness in its new environment—such as Indiana breast tissue—before it is cleared.

This has led to a phenomenon known as “predicate creep.” For example, the manufacturer of GalaFLEX cited a surgical suture as one of its predicates. While a suture might be safe for closing a small incision, using a large sheet of the same material to support a breast implant is a fundamentally different use. On November 9, 2023, the FDA issued a critical letter to health care providers stating: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”

For a woman in Indiana who underwent reconstruction after a mastectomy, this revelation is often the first time she realizes she was part of a large-scale, off-label medical experiment. If you are in Indiana and were not informed of the off-label status of your surgical mesh or ADM, your right to informed consent may have been violated.

The Complication Spectrum: Identifying Injuries in Indiana

The injuries associated with defective breast mesh and scaffolds in Indiana can be devastating, both physically and emotionally. Our firm, lead by Ralph Manginello, recognizes that these are not just “side effects”—they are serious medical injuries that often require multiple corrective surgeries.

BIA-ALCL and BIA-SCC (Oncological Complications)

The most severe risks involve two types of malignancies associated with breast implants and the surrounding scar tissue (capsule).

• BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma): This is a CD30-positive, ALK-negative T-cell lymphoma recognized by the World Health Organization. It is frequently associated with the textured surface of Allergan BIOCELL implants, which were recalled in July 2019.
• BIA-SCC (Breast Implant-Associated Squamous Cell Carcinoma): A more recently documented tumor identified by the FDA in September 2022. It presents in the capsule and has been linked to a latency period of up to 42 years.

Indiana patients diagnosed with these conditions often require total capsulectomy and implant removal.

Red Breast Syndrome (RBS) and Endotoxin Science

Many Indiana women experience a persistent, non-infectious redness of the breast after ADM implantation. This is known as Red Breast Syndrome (RBS). Scientific literature, including studies by Nguyen et al. (2019), suggest that RBS is often an inflammatory reaction to endotoxins—fragments of bacteria that remain on the biologic matrix even after sterilization. Because these matrices are “aseptically processed” rather than terminally sterilized, the host immune system in the Indiana patient recognizes these fragments, leading to chronic inflammation.

Structural and Infectious Failures

In addition to rare cancers, we see a high volume of the following injuries in Indiana:

• Skin-flap necrosis: Death of the breast tissue overlying the implant.
• Capsular Contracture: Hardening of the scar tissue that deforms the breast.
• Mesh Extrusion: The device physically eroding through the skin.
• Biofilm-mediated infections: Bacteria clinging to the mesh surface, creating “super-infections” that are resistant to standard antibiotics available in Indiana hospitals.

If you are experiencing any of these symptoms in Indiana, it is vital to secure your medical records and contact 1-888-ATTY-911. lupe Peña and our team are ready to investigate whether a defective device is the root cause of your pain.

The Whistleblower Fact: BD and the GalaFLEX Controversy

Indiana patients should be aware of the whistleblower record of Dr. Hooman Noorchashm. A former Medical Director at Becton Dickinson (BD), Dr. Noorchashm was reportedly terminated in 2022 after raising alarms regarding the safety of GalaFLEX and other mesh products in breast surgery. He alleged that the company withheld data regarding breast cancer recurrences in clinical trials and ignored adverse event reports.

This insider information is a cornerstone of our technical authority at Attorney911. When we represent a woman in Indiana, we aren’t just looking at her individual chart; we are looking at the corporate history of the manufacturers who put profit over Hoosier lives.

Indiana Legal Framework: Statutes and Venue

Navigating a product liability claim in Indiana requires a deep understanding of the Indiana Product Liability Act (IPLA). If you are injured in Indiana, your case is governed by specific rules that differ from other states:

1. Statute of Limitations: In Indiana, you generally have two years from the date your injury occurred or the date you discovered (or should have discovered) that the device caused the injury.
2. Statute of Repose: Indiana has a strict ten-year statute of repose. This means that if your device was delivered to you more than ten years ago, your claim may be barred entirely, regardless of when you discovered the injury. This makes immediate action critical for Indiana residents.
3. Modified Comparative Fault: Indiana follows a 51% fault rule. If you are more than 50% at fault for your own injury, you cannot recover. In medical device cases, however, the fault almost always lies with the manufacturer or the surgical team, not the patient.
4. Federal Venue: Cases filed by Indiana residents are often heard in the United States District Court for the Southern District of Indiana (Indianapolis) or the Northern District (South Bend/Fort Wayne). As a firm admitted to the federal Southern District of Texas, Ralph Manginello is equipped to handle complex federal device litigation that often spans multiple jurisdictions.

Why Attorney911 is the Choice for Indiana Families

When choosing an attorney for a breast mesh or ADM case in Indiana, experience and credentials matter. You are not just hiring a lawyer; you are hiring a team to stand up to multi-billion dollar corporations like AbbVie and Becton Dickinson.

• Verified Reliability: Ralph Manginello holds an Avvo Rating of 8.2 (Excellent) and a perfect 5.0/5.0 client review score across dozens of verified reviews. Our firm has earned over 400 five-star reviews on Birdeye, reflecting our commitment to client communication.
• Bilingual Capability: Indiana has a growing Spanish-speaking community. Lupe Peña’s ability to conduct full legal consultations in Spanish (Hablamos Español) ensures that every Indiana family has access to justice without language barriers.
• Institutional Litigation Power: Our work in the Bermudez v. Pi Kappa Phi case, seeking $10,000,000 in damages against national organizations and universities, proves we have the structural power to handle cases with thirteen or more defendants. We bring that same aggressive posture to Indiana device litigation.
• Pro Bono Ethics: Ralph Manginello is a member of the Pro Bono College of the State Bar of Texas, a distinction reserved for those who donate at least 75 hours of service annually. This reflects our firm’s core value: helping people who have been silenced.

Frequently Asked Questions for Indiana Patients

Is breast mesh approved by the FDA for use in Indiana surgeries?
No. As of 2024, the FDA has not approved or cleared any surgical mesh product specifically for use in breast reconstruction or augmentation. Their “clearance” is for general tissue reinforcement, and use in the breast is considered “off-label.”

Can I sue if my GalaFLEX scaffold didn’t dissolve?
Yes. Bioabsorbable scaffolds like GalaFLEX are marketed to dissolve within 18 to 24 months. If your scaffold is still palpable, causing pain, or visible on imaging years later, it represents a mechanical failure and a potential design defect.

What if I live in a rural part of Indiana?
We serve the entire state of Indiana. Regardless of whether you are in Indianapolis or a small town, 1-888-ATTY-911 is your direct line to a firm with federal litigation capability. We can handle your records requests and initial consultations remotely to minimize your travel burden.

What does it cost to hire Attorney911?
We work on a contingency fee basis. This means there is no upfront cost to you. We only get paid if we recover compensation for your medical bills, lost wages, and pain and suffering. If we don’t win, you don’t owe us an attorney fee.

Is this a class action?
Most defective device cases are handled as Mass Torts or Multidistrict Litigation (MDL). For example, the Allergan BIOCELL cases are centralized in MDL 2921. This allows your individual case in Indiana to benefit from the shared resources of thousands of plaintiffs while still being decided on its own merits.

Recovering Compensation in Indiana

The financial toll of a failed reconstruction or a mesh-related infection in Indiana is staggering. Beyond the physical pain, there is “financial toxicity.” A 2024 study in Women’s Health Issues found that complications lead to an average cost increase of $7,000 per patient in the first year alone. Indiana law allows you to seek damages for:

• Future Medical Expenses: For the five to eight revision surgeries often required to fix a mesh injury.
• Lost Earning Capacity: If your complications prevent you from returning to work in Indiana.
• Pain and Suffering: The emotional distress of losing a reconstruction after surviving cancer.
• Punitive Damages: In cases where we can prove the manufacturer intentionally concealed safety data.

Practical Steps for Indiana Residents

If you suspect your surgical mesh or ADM is failing, do not wait. Indiana’s ten-year statute of repose is unforgiving.

1. Request Your “Implant Stickers”: Every device used in a surgery in Indiana comes with a lot number and UDI (Unique Device Identifier). These stickers are in your hospital records.
2. Request Your Operative Report: This document will name the specific brand (e.g., Strattice, GalaFLEX) used by your Indiana surgeon.
3. Preserve the Evidence: If you are having the mesh removed in Indiana, instruct your surgeon to preserve the explanted material. It is your property and critical evidence.
4. Contact Attorney911: Call 1-888-ATTY-911. We will help you navigate the records request process and determine if you have a viable claim under Indiana law.

Contact Indiana Defective Breast Mesh Lawyers Today

You have been through enough. Between the initial diagnosis and the surgeries that were supposed to make you whole, you have shown incredible strength. Now, let us be your strength in the courtroom.

Whether you are in Indianapolis, Gary, Evansville, or anywhere else in Indiana, help is one phone call away. Our managing partner Ralph Manginello and associate Lupe Peña are ready to listen to your story and hold these manufacturers accountable for the harm they have caused Indiana families.

Call 1-888-ATTY-911 (1-888-288-9911) today for your free, confidential consultation. Hablamos Español. Si usted o un ser querido en Indiana ha sido afectado por una malla mamaria defectuosa, llámenos ahora para una consulta gratuita y profesional.

Attorney Advertising. The Manginello Law Firm, PLLC. Principal office: 1177 West Loop South, Suite 1600, Houston, TX 77027. Ralph Manginello is licensed in Texas and admitted to the Southern District of Texas. Past results do not guarantee future outcomes. This content is for educational purposes and does not constitute medical or legal advice.